1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Top Countries

  • All
    • East Asia
97 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2020

  • $ 3495
  • April 2020
  • 400 pages

Lymphoma Society, LifeLink Foundation, LifeLiver, LifeQ, LineaRx, Lipidor, LogicNets, Loreal, Louisiana State University, Loxo Oncology, Lupin Limited, Luye Pharma Group, Macrogen, MAKScientific, Mallinckrodt Pharmaceuticals, Marina Biotech, Marshall Institute for Interdisciplinary Research

  • Biotechnology
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • East Asia

NHL: Diffuse large Bcell lymphoma

  • $ 5000
  • May 2016
  • 219 pages

Immunophenotyping also needs to be robust enough to distinguish the disease from other lymphomas which resemble DLBCL in morphology, such as mantle cell lymphoma and Burkitt' s lymphoma.

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • East Asia

Hodgkin’s Lymphoma - Opportunity Analysis and Forecasts to 2029

  • $ 10995
  • June 2020
  • 140 pages

M. (2019) CANCER, LYMPHOMA, HODGKIN, STATPEARLS.

  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
  • East Asia

NHL: Follicular lymphoma

  • $ 5000
  • April 2016
  • 252 pages

NHL: Follicular lymphoma Disease Coverage | Treatment: Follicular Lymphoma practices.

  • Healthcare
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • East Asia

NHL: Mantle cell lymphoma

  • $ 5000
  • April 2016
  • 214 pages

Lymphoma Association (2016) Mantle cell lymphoma.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • East Asia

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 212 pages

BAY-##, AN ORAL ATR INHIBITOR, IS BEING INVESTIGATED IN A PHASE I STUDY (BAYER, NCT##) IN SOLID TUMORS (INCLUDING PCA) AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Prostate Cancer
  • Therapy
  • East Asia

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • $ 3499
  • April 2018
  • 850 pages

LEUKEMIA AND LYMPHOMA ##. ##. ##. ##.

  • Immunotherapy
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • East Asia

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • March 2019
  • 164 pages

THE LEUKEMIA AND LYMPHOMA SOCIETY (2015) MYELOMA.

  • Cancer
  • Cancer Hormonal Therapy
  • Lymphoma
  • Therapy
  • East Asia

Colorectal Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 153 pages

FRANCE AND GERMANY ITALY SPAIN TO DETERMINE THE DISTRIBUTION OF DIAGNOSED INCIDENT CASES OF CRC BY STAGE AT DIAGNOSIS IN SPAIN, A RETROSPECTIVE FOLLOW-UP STUDY OF INDIVIDUALS DIAGNOSED WITH CRC (EXCLUDING CASES WITH DEATH CERTIFICATE-ONLY INFORMATION AND LYMPHOMAS) DURING 2006-2011 WAS USED

  • Colorectal Cancer
  • Lymphoma
  • Targeted Therapy
  • Therapy
  • East Asia

Contract Research Organizations (CRO) Global Market Opportunities And Strategies To 2022

  • $ 4000
  • March 2020
  • 415 pages

The Business Research Company March 2020 Contract Research Organizations (CRO) Global Market Opportunities And Strategies To 2022 Executive Summary This report describes and evaluates the global CRO market.

  • Clinical Trial
  • Drug Development
  • Lymphoma
  • East Asia
  • Market Size

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • April 2020
  • 204 pages

Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028 Summary Age-related macular degeneration (AMD) is an eye condition that is characterized by the gradual deterioration ...

  • Lymphoma
  • Ophthalmology
  • Targeted Therapy
  • Therapy
  • East Asia

China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

  • $ 2200
  • August 2017
  • 357 pages

Lymphoma ##.

  • Cancer
  • Lymphoma
  • Pathology
  • China
  • East Asia

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 228 pages

So the CAR T, for example, represents a cure of lymphoma and leukemia.

  • Blood Disease
  • Lymphoma
  • Pathology
  • Therapy
  • East Asia

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • January 2019
  • 201 pages

ALTHOUGH CELLTRION' S TRUXIMA WAS SIMILARLY TREATED BY THE FDA, THE COMPANY COMPLIED WITH REQUESTS FOR ADDITIONAL DATA AND IN NOVEMBER 2018, CELLTRION' S TRUXIMA WAS APPROVED, BUT ONLY FOR THE TREATMENT OF B-CELL NON-HODGKIN AND FOLLICULAR LYMPHOMAS (CELLTRION, PRESS RELEASE, ## NOV

  • Biosimilar
  • Hospital
  • Lymphoma
  • Therapy
  • East Asia

The Chinese Pharmaceutical Market to 2030

  • $ 3000
  • March 2020
  • 101 pages

-Increase your foothold in the Chinese market TODAY -Establish partnerships to manufacture, distribute or develop Chinese products -Scope out the market prior to entry   This new report covers the ...

  • Pharmaceutical
  • China
  • East Asia
  • Fosun International Limited
  • Pfizer China

Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment, Number of Patients Treated, Specifications & Company Analysis - Global Forecast to 2024

  • $ 2390
  • July 2018
  • 429 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Lymphoma
  • Specialty Hospital
  • East Asia
  • Forecast
  • Market Size

World Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis

  • $ 37500
  • June 2019
  • 1175 pages

Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/ RNA Analysis, Cell Culturing Instrumentation Review - Reviews of current instrumentation Technologies, and featu

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • East Asia
  • World

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • November 2016
  • 608 pages

ANAPLASTIC LYMPHOMA KINASE INHIBITION IN NON-SMALL-CELL LUNG CANCER.

  • Hospital
  • Lung Cancer
  • Lymphoma
  • Therapy
  • East Asia

Japan IVD Market Size, Share, Major Deals & Company Analysis – Forecast to 2025

  • $ 1990
  • February 2019
  • 128 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • In Vitro Diagnostics
  • Laboratory
  • Lymphoma
  • East Asia
  • Japan

Colorectal Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • November 2019
  • 47 pages

TO DETERMINE THE DISTRIBUTION OF DIAGNOSED INCIDENT CASES OF CRC BY STAGE AT DIAGNOSIS IN SPAIN, A RETROSPECTIVE FOLLOW-UP STUDY OF INDIVIDUALS DIAGNOSED WITH CRC (EXCLUDING CASES WITH DEATH CERTIFICATE-ONLY INFORMATION AND LYMPHOMAS) DURING 2006-2011 WAS USED TO DETERMINE THE DISTRIBUTION

  • Cancer
  • Colorectal Cancer
  • Lymphoma
  • Pathology
  • East Asia
View report >

Gasoline Market

  • October 2019
  • 144 pages

A recent study shows that among national cost in the United States female breast was the cancer site with the highest cost in 2010 ($##. ## billion) followed by colorectal ($##. ## billion), lymphoma ($##. ## billion), lung ($##. ## billion), and prostate ($##. ## billion).

  • Fuels
  • Gasoline
  • Lymphoma
  • Motor Vehicle
  • East Asia

Therapy Market January 2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on